← Leaderboards
Natalia Martinez
National Center For Advancing Translational Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Center For Advancing Translational Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsScreeningCellsSmall Molecule InhibitorNational Center For Advancing Translational SciencesSmall MoleculeHigh Throughput ScreeningLibrariesInhibitorMalignant NeoplasmsBiochemicalGenesBindingMiniaturizeSmall Molecule LibrariesInterestRecombinantsReportingStructureImplementation EvaluationPharmacotherapyOverexpressionPlayEvaluation
Grant awards (15)
Identification of small molecule inhibitors of USP15$278,962
ZIA · FY2025 · TR · contact PI
Screening for B. burgdorferi borreliacidal/borreliastatic compounds$278,962
ZIA · FY2025 · TR · contact PI
Screening for small molecule degraders of KDM5A & B$278,962
ZIA · FY2025 · TR · contact PI
Identification of small molecule inhibitors of USP18$278,962
ZIA · FY2025 · TR · contact PI
Discovery of single-domain antibodies targeting CD206$278,962
ZIA · FY2025 · TR · contact PI
Novel Pharmacotherapies for Metastatic Bladder Cancer$278,962
ZIA · FY2025 · TR · contact PI
Identification of HSP70 activators$278,962
ZIA · FY2025 · TR · contact PI
Identification of small molecule inhibitors and activators of cytochrome B5 reductases (CYB5Rs)$278,962
ZIA · FY2025 · TR · contact PI
NADPH-oxidase 2 inhibitors for cardiovascular indications$209,221
ZIA · FY2025 · TR · contact PI
Identifying inhibitors of ER retrotranslocation/dislocation$209,221
ZIA · FY2025 · TR · contact PI
In vitro screen for inhibitors of the inositol kinases ITPK1 and PPIP5K$139,481
ZIA · FY2025 · TR · contact PI
Identification of IMiD Analogs with Anti-infective activity$69,740
ZIA · FY2025 · TR · contact PI
Development of novel biophysical assays to measure binding kinetics$69,740
ZIA · FY2025 · TR · contact PI
Discovery of single-domain antibodies targeting fibril plaques$69,740
ZIA · FY2025 · TR · contact PI
Antivirals for Rare, Emerging and Endemic Viruses of the Class Bunyaviricetes$69,740
ZIA · FY2025 · TR · contact PI